A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry

Clinica Chimica Acta

Volumn 420, Issue , 2013, Pages 34-44

  Tyan, Yu Chang ^a,b   Su, Shih Bin ^c   Ting, Sing Sing ^d   Wang, Hsien Yi ^c,e   Liao, Pao Chi ^d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Peritoneal dialysate; Peritoneal dialysis; Peritonitis; Proteomics

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTITHROMBIN III; APOLIPOPROTEIN A1; CERULOPLASMIN; FIBRINOGEN; FIBRINOGEN BETA; FIBRINOGEN GAMMA; GLYCOPROTEIN; HAPTOGLOBIN; HEAT SHOCK PROTEIN 70; INTER ALPHA TRYPSIN INHIBITOR HEAVY CHAIN H4; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG; ZINC ALPHA 2 GLYCOPROTEIN;

ARTICLE; COMPARATIVE STUDY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REVERSED PHASE NANO HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MASS SPECTROMETRY; PERITONEAL DIALYSIS; PERITONITIS; PROTEINS; PROTEOMICS;

EID: 84877624268     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.10.010     Document Type: Article

References (37)

1. Schilte M.N., Celie J.W., Wee P.M., Beelen R.H., van den Born J. Factors contributing to peritoneal tissue remodeling in peritoneal dialysis. Perit Dial Int 2009, 29:605-617.
2. Wu G., Khanna R., Vas S.I., Digenis G., Oreopoulos D.G. Continuous ambulatory peritoneal dialysis: no longer experimental. Can Med Assoc J 1984, 130:699-707.
3. Williams J.D., Craig K.J., Topley N., et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002, 13:470-479.
4. Tyan Y.C., Liao P.C. Proteomics analysis of serous fluids and effusions: pleural, pericardial, and peritoneal. Proteomics Clin Appl 2007, 1:834-844.
5. Davies S.J., Phillips L., Naish P.F., Russell G.I. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001, 12:1046-1051.
6. Hung K.Y., Lin T.J., Tsai T.J., Chen W.Y. Impact of peritoneal membrane transport on technique failure and patient survival in a population on automated peritoneal dialysis. ASAIO J 1999, 45:568-573.
7. Li P.K., Chan T.H., So W.Y., Wang A.Y., Leung C.B., Lai K.N. Comparisons of Y-set disconnect system (Ultraset) versus conventional spike system in uremic patients on continuous ambulatory peritoneal dialysis: outcome and cost analysis. Perit Dial Int 1996, 16:368-370.
8. Li P.K., Szeto C.C., Law M.C., et al. Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis-a randomized prospective multi-center study. Am J Kidney Dis 1999, 33:535-540.
9. Li P.K., Law M.C., Chow K.M., et al. Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis - a prospective randomized controlled multi-center study. Am J Kidney Dis 2002, 40:373-380.
10. Rubin J., McFarland S., Hellems E.W., Bower J.D. Peritoneal dialysis during peritonitis. Kidney Int 1981, 19:460-464.
11. Lamb E.J., Worall J., Buhler R., Harwood S., Cattell W.R., Dawnay A.B. Effect of diabetes and peritonitis on the peritoneal equilibration test. Kidney Int 1995, 47:1760-1767.
12. Davies S.J., Bryan J., Phillips L., Russell G.I. Longitudinal changes in peritoneal kinetics; the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996, 11:498-506.
13. Wong T.Y., Szeto C.C., Lai K.B., Lam C.W., Lai K.N., Li P.K. Longitudinal study of peritoneal membrane function in continuous ambulatory peritoneal dialysis: relationship with peritonitis and fibrosing factors. Perit. Dial. Int. 2000, 20:679-685.
14. Ota K., Mineshima M., Watanabe N., Naganuma S. Functional deterioration of the peritoneum: does it occur in the absence of peritonitis?. Nephrol Dial Transplant 1987, 2:30-33.
15. Selgas R., Fernandez-Reyes M.J., Bosque E., et al. Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 1994, 23:64-73.
16. Hung S.Y., Chung H.M. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients. Adv. Perit. Dial. 2001, 17:196-199.
17. Keane F.W., Bailie R.G., Boeschoter E., et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit. Dial. Int. 2000, 20:396-411.
18. Wasinger V.C., Cordwell S.J., Cerpa-Poljak A., et al. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 1995, 16:1090-1094.
19. Yang M.H., Yang Y.H., Lu C.Y., et al. Activity-dependent neuroprotector homeobox protein: a candidate protein identified in serum as diagnostic biomarker for Alzheimer's disease. J Proteomics 2012, 75:3617-3629.
20. Tyan Y.C., Wu H.Y., Su W.C., Chen P.W., Liao P.C. Proteomic analysis of human pleural effusion. Proteomics 2005, 5:1062-1074.
21. Yang M.H., Jong S.B., Lu C.Y., Lin Y.F., Chiang P.W., Tyan Y.C., et al. Assessing the responses of cellular proteins induced by hyaluronic acid-modified surfaces utilizing mass spectrometry-based profiling system: over-expression of CD36, CD44, CDK9, and PP2A. Analyst 2012, 137:4921-4933.
22. Pons M., Ihrke G., Koch S., et al. Late endocytic compartments are major sites of annexin VI localization in NRK fibroblasts and polarized WIF-B hepatoma cells. Exp Cell Res 2000, 257:33-47.
23. Musiał K., Zwolińska D. Heat shock proteins in chronic kidney disease. Pediatr Nephrol 2011, 26:1031-1037.
24. Aufricht C. Heat-shock protein 70: molecular supertool?. Pediatr Nephrol 2005, 20:707-713.
25. Shioshita K., Miyazaki M., Ozono Y., et al. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis. Kidney Int 2000, 57:619-631.
26. Diamandis E.P. Peptidomics for cancer diagnosis: present and future. J Proteome Res 2006, 5:2079-2082.
27. Piñeiro M., Alava M.A., González-Ramón N., et al. ITIH4 serum concentration increases during acute-phase processes in human patients and up-regulated by interleukin-6 in hepatocarcinoma HepG2 cells. Biochem Biophys Res Commun 1999, 263:224-229.
28. Wang Z., Yip C., Ying Y., et al. Mass spectrometric analysis of protein markers for ovarian cancer. Clin Chem 2004, 50:1939-1942.
29. Montanelli A., Mainardi E., Pini L., Corda L., Grassi V. Alpha-1-antitrypsin deficiency and nephropathy. Nephron 2002, 90:114-115.
30. Lisowska-Myjak B. AAT as a diagnostic tool. Clin. Chim. Acta 2005, 352:1-13.
31. Zacharowski K., Zacharowski P., Reingruber S., Petzelbauer P. Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction. J Mol Med 2006, 84:469-477.
32. Tomura S., Nakamura Y., Doi M., et al. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1996, 27:848-854.
33. Kim S.B., Lee S.K., Park J.S., Chi H.S., Hong C.D., Yang W.S. Effects of fixed low-dose warfarin on hemostatic factors in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 2001, 37:343-347.
34. Malyszko J., Suchowierska E., Malyszko J.S., Mysliwiec M. A comprehensive study on hemostasis in CAPD patients treated with erythropoietin. Perit Dial Int 2002, 22:582-592.
35. Wang H.Y., Tian Y.F., Chien C.C., et al. Differential proteomic characterization between normal peritoneal fluid and diabetic peritoneal dialysate. Nephrol Dial Transplant 2010, 25:1955-1963.
36. Tyan Y.C., Wu H.Y., Lai W.W., Su W.C., Liao P.C. Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry. J Proteome Res 2005, 4:1274-1286.
37. Wang H.Y., Lin C.Y., Chien C.C., et al. Impact of uremic environment on peritoneum: a proteomic view. J Proteomics 2012, 75:2053-2063.